These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12649092)

  • 21. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
    Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
    Dunér P; To F; Beckmann K; Björkbacka H; Fredrikson GN; Nilsson J; Bengtsson E
    Cardiovasc Res; 2011 Aug; 91(3):528-36. PubMed ID: 21493703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
    Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
    Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
    Pedersen TX; Binder CJ; Fredrikson GN; Nilsson J; Bro S; Nielsen LB
    Nephrol Dial Transplant; 2010 Aug; 25(8):2486-91. PubMed ID: 20164045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
    Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
    Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C; Gomez M; Calvo E; López JA; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):27-32. PubMed ID: 18988893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
    Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet activation by the apoB/E receptor-binding domain of LDL.
    Relou AM; Gorter G; van Rijn HJ; Akkerman JW
    Thromb Haemost; 2002 May; 87(5):880-7. PubMed ID: 12038793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.